MedPath

CT in Diagnosing Patients With Lung Cancer

Not Applicable
Completed
Conditions
Lung Cancer
Interventions
Procedure: computed tomography
Procedure: 4-dimensional computed tomography
Procedure: cone-beam computed tomography
Registration Number
NCT01888510
Lead Sponsor
Virginia Commonwealth University
Brief Summary

This clinical trial studies computed tomography (CT) in diagnosing patients with lung cancer. Diagnostic procedures, such as CT, may help find and diagnose lung cancer.

Detailed Description

PRIMARY OBJECTIVES:

I. Conduct a prospective clinical imaging study to quantify the amount of inter- and intra-physician contouring variability on four dimensional (4D) CT, active breathing control (ABC) CT, free breathing CT, and free breathing and ABC cone beam (CB)CT.

II. Quantify the magnitude and distribution of target and organ at risk volume variations between the different imaging modalities.

III. Determine dosimetric changes related to contouring variations for tumor and normal tissue.

OUTLINE:

Patients undergo conventional free breathing CT, 4D CT, ABC CT, ABC CBCT, and free breathing CBCT before undergoing radiation therapy.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
10
Inclusion Criteria
  • Measurable disease on CT scan
  • Patients with lung cancer visible on CT who are scheduled to receive external beam radiation treatment will be eligible for this study
  • Patients must be able to perform ABC procedures
Exclusion Criteria
  • Patients requiring continuous supplemental oxygen due to the requirement of spirometry during all imaging studies
  • No vulnerable populations will be enrolled (prisoners, children, pregnant females or institutionalized individuals)
  • Women of childbearing potential will undergo a pregnancy test

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Diagnostic (imaging studies)4-dimensional computed tomographyPatients undergo conventional free breathing CT, 4D CT, ABC CT, ABC CBCT, and free breathing CBCT before undergoing radiation therapy.
Diagnostic (imaging studies)cone-beam computed tomographyPatients undergo conventional free breathing CT, 4D CT, ABC CT, ABC CBCT, and free breathing CBCT before undergoing radiation therapy.
Diagnostic (imaging studies)computed tomographyPatients undergo conventional free breathing CT, 4D CT, ABC CT, ABC CBCT, and free breathing CBCT before undergoing radiation therapy.
Primary Outcome Measures
NameTimeMethod
Amount of inter- and intra-physician contouring variability on 4D CT, ABC CT, free breathing CT, and free breathing and ABC CBCTup to 1 week

A two sided t-test with 5% level of significance will be used.

Secondary Outcome Measures
NameTimeMethod
Magnitude and distribution of target and organ at risk volume variations between the different imaging modalitiesup to 1 week

A two sided t-test with 5% level of significance will be used.

Dosimetric changes related to contouring variations for tumor and normal tissueup to 1 week

A two sided t-test with 5% level of significance will be used.

Trial Locations

Locations (1)

Virginia Commonwealth University/Massey Cancer Center

🇺🇸

Richmond, Virginia, United States

© Copyright 2025. All Rights Reserved by MedPath